Try GOLD - Free
Coding and FDCE: Redefining regulatory compliance in healthcare
Express Pharma
|December 2025
Abhijeet Vaidya, Head of Data & AI Practice, Emids opines that as AI reshapes healthcare technology, regulatory compliance is shifting from rigid, rule-based systems to adaptive, intelligent frameworks. Concepts like Vibe Coding and FDCE are enabling this transformation
-
Regulatory compliance in healthcare and life sciences traditionally relied on rigid, rule-based systems, often treated as a checklist rather than a dynamic capability. With artificial intelligence reshaping how organisations design and deploy digital systems, compliance itself is undergoing a transformation.
Two emerging concepts such as Vibe Coding and Forward-Deployed Context Engineers (FDCE) are helping organisations shift from reactive oversight to proactive, context-aware compliance. But before diving into these ideas, it's important to understand how software development has evolved.
For decades, enterprise software followed a deterministic path, built around clearly defined business rules, workflows, and user requirements. In contrast, Al-driven development operates on probabilistic systems that learn from data and evolve over time. The difference is not just technical; it is philosophical.
In a traditional setup, or enterprise approach, engineers define exactly how the system should behave. In an AI-driven setup, however, engineers teach the system to learn from data and experience. For example, a nurse manually tracking patient cases represents the enterprise approach, while an AI model that predicts which patients are at risk of hospitalisation in the next 30 days reflects the datadriven mindset. Similarly, the enterprise approach might create a rule-based claims processing system that flags high-value claims, whereas an AI-driven system can detect subtle anomalies to identify potential fraud or waste.
This story is from the December 2025 edition of Express Pharma.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Express Pharma
Express Pharma
Future opportunities in biologics and biosimilars will demand significant investment
Semaglutide's patent expiry in India in March 2026 has become the immediate trigger for the next wave of pharmaceutical development activity, but the larger opportunity goes well beyond semaglutide itself.
1 mins
April 2026
Express Pharma
Gandhi Automations elevates loading bay efficiency with advanced dock leveler solutions
Engineered systems from Gandhi Automations Pvt Ltd enhance safety, durability and seamless material flow
2 mins
April 2026
Express Pharma
Redefining humidity control in pharma manufacturing
Bry-Air systems reflect shift towards material-based humidity control in pharma manufacturing
2 mins
April 2026
Express Pharma
2026 amendments to NDCT Rules: Foreword to India's biosimilars story or a step too short?
Kosturi Ghosh, Partner, and Ajeya B G, Sr Associate, in the Corporate practice at Trilegal, assess India's 2026 NDCT amendments as a timely push for biosimilars, but not enough on their own. The article highlights that stronger policy clarity and ecosystem support will be critical to truly unlock growth.
4 mins
April 2026
Express Pharma
Optima advances digital twins to boost efficiency in pharmaceutical turnkey machines
Virtual testing, training and simulation tools enhance performance in complex manufacturing environments
7 mins
April 2026
Express Pharma
Complete environmental monitoring solution – testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
3 mins
April 2026
Express Pharma
Flexotherm heating tapes & cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
April 2026
Express Pharma
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover other critical drug categories in phases, all segments of the pharma value chain need to tighten their systems, analyses Viveka Roychowdhury
15 mins
April 2026
Express Pharma
This is only the beginning of a much larger global patent-cliff cycle
As the patent expiry of semaglutide is almost there in India, several Indian pharma firms are preparing to introduce generic versions, highlighting the sector's agility in responding to high-value loss-of-exclusivity opportunities.
1 min
April 2026
Express Pharma
Leading people in the age of Al
As Al reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and work, finds Lakshmipriya Nair
8 mins
April 2026
Listen
Translate
Change font size

